Jsafra-Asset-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-25
Total Holdings
305
Total Value
1199167396
Accession Number
0001535293-25-000003
Form Type
13F-HR
Manager Name
Jsafra-Asset-Management
Data Enrichment
88% identified
269 identified36 unidentified

Holdings

305 positions • $1.2B total value
Manager:
Search and click to pin securities to the top
Page 14 of 16
ROCKY BRANDS, INC.
Shares:354
Value:$6.1K
% of Portfolio:0.0% ($6.1K/$1.2B)
Celldex Therapeutics, Inc.
Shares:330
Value:$6.0K
% of Portfolio:0.0% ($6.0K/$1.2B)
CALERES INC
Shares:318
Value:$5.5K
% of Portfolio:0.0% ($5.5K/$1.2B)
Penumbra Inc
Shares:13
Value:$3.5K
% of Portfolio:0.0% ($3.5K/$1.2B)
MASIMO CORP
Shares:15
Value:$2.5K
% of Portfolio:0.0% ($2.5K/$1.2B)
INSULET CORP
Shares:9
Value:$2.4K
% of Portfolio:0.0% ($2.4K/$1.2B)
ALNYLAM PHARMACEUTICALS, INC.
Shares:7
Value:$1.9K
% of Portfolio:0.0% ($1.9K/$1.2B)
STRYKER CORP
Shares:4
Value:$1.5K
% of Portfolio:0.0% ($1.5K/$1.2B)
EXACT SCIENCES CORP
Shares:31
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$1.2B)
VEEVA SYSTEMS INC
Shares:5
Value:$1.2K
% of Portfolio:0.0% ($1.2K/$1.2B)
Privia Health Group, Inc.
Shares:49
Value:$1.1K
% of Portfolio:0.0% ($1.1K/$1.2B)
GILEAD SCIENCES, INC.
Shares:9
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$1.2B)
Alignment Healthcare, Inc.
Shares:51
Value:$950
% of Portfolio:0.0% ($950/$1.2B)
Legend Biotech Corp
Shares:28
Value:$950
% of Portfolio:0.0% ($950/$1.2B)
CVS HEALTH Corp
Shares:13
Value:$881
% of Portfolio:0.0% ($881/$1.2B)
Surgery Partners, Inc.
Shares:36
Value:$855
% of Portfolio:0.0% ($855/$1.2B)
Royalty Pharma plc
Shares:26
Value:$809
% of Portfolio:0.0% ($809/$1.2B)
Inspire Medical Systems, Inc.
Shares:5
Value:$796
% of Portfolio:0.0% ($796/$1.2B)
GLAUKOS Corp
Shares:8
Value:$787
% of Portfolio:0.0% ($787/$1.2B)
BrightSpring Health Services, Inc.
Shares:39
Value:$706
% of Portfolio:0.0% ($706/$1.2B)